| Nine Entertainment Co. Holdings Limited (NEC) ORDINARY FULLY PAID |
Communication Services |
$1,855 |
Initial Director's Interest Notice - Peter Tonagh
|
14 Jan 2025 9:20AM |
$1.285 |
$1.170 |
fallen by
8.95%
|
|
| Osteopore Limited (OSX) ORDINARY FULLY PAID |
Health Care |
$2 |
Osteopore added to Singapore Ministry of Health subsidy list
|
14 Jan 2025 9:20AM |
$0.035 |
$0.008 |
fallen by
77.14%
|
|
| Highfield Resources Limited (HFR) ORDINARY FULLY PAID |
Materials |
$26 |
Yankuang Energy Receives FIRB Approval
|
14 Jan 2025 9:19AM |
$0.245 |
$0.055 |
fallen by
77.55%
|
|
HFR - Price-sensitive ASX Announcement
Full Release
Key Points
- Yankuang Energy received FIRB approval for investment in Highfield Resources.
- Yankuang Energy's subscription totals up to US$376 million.
- The investment is part of a total US$220 million equity capital raise by Highfield.
- Highfield plans to acquire the Southey potash project for US$286 million.
- FIRB approval is a crucial condition for the transaction completion.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Norwood Systems Limited (NOR) ORDINARY FULLY PAID |
Information Technology |
$7 |
Notification regarding unquoted securities - NOR
|
14 Jan 2025 9:19AM |
$0.031 |
$0.013 |
fallen by
58.06%
|
|
| Great Boulder Resources Limited (GBR) ORDINARY FULLY PAID |
Materials |
$105 |
New targets confirmed with AC drilling at Whiteheads
|
14 Jan 2025 9:19AM |
$0.047 |
$0.100 |
risen by
112.77%
|
|
| NewPeak Metals Limited (NPM) ORDINARY FULLY PAID |
Materials |
$9 |
Lakes Blue PEP 169 Sale Second and Final Payment Received
|
14 Jan 2025 9:18AM |
$0.013 |
$0.027 |
risen by
107.69%
|
|
| Humm Group Limited (HUM) ORDINARY FULLY PAID |
Financials |
$368 |
Change of Company Secretary
|
14 Jan 2025 9:17AM |
$0.600 |
$0.735 |
risen by
22.50%
|
|
| Amcor Plc (AMC) CDI 1:1 FOREIGN EXEMPT NYSE |
Materials |
$29,919 |
Form 425
|
14 Jan 2025 9:17AM |
$15.330 |
$12.950 |
fallen by
15.53%
|
|
AMC - Price-sensitive ASX Announcement
Full Release
Key Points
- Amcor plc filed a preliminary joint proxy statement/prospectus with the SEC on January 13, 2025.
- The filing is related to the proposed merger with Berry Global Group, Inc.
- It includes unaudited pro forma combined financial information and key financial metrics.
- Investors are urged to read the joint proxy statement/prospectus and related documents carefully.
- Forward-looking statements include estimates and assumptions that are subject to change.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| WCM Global Growth Limited (WQG) ORDINARY FULLY PAID |
Financials |
$443 |
Weekly NTA 10 January 2025
|
14 Jan 2025 9:17AM |
$1.665 |
$1.945 |
risen by
16.82%
|
|
| Hastings Technology Metals Limited (HAS) ORDINARY FULLY PAID |
Materials |
$128 |
Application for quotation of securities - HAS
|
14 Jan 2025 9:16AM |
$0.345 |
$0.575 |
risen by
66.67%
|
|
| Cardno Limited (CDD) ORDINARY FULLY PAID |
Industrials |
- |
Update on voluntary delisting from the ASX
|
14 Jan 2025 9:16AM |
$0.145 |
$0.140 |
fallen by
3.45%
|
|
CDD - Price-sensitive ASX Announcement
Full Release
Key Points
- Cardno Limited announced an update on its voluntary delisting from ASX.
- The delisting resolution was passed at the Annual General Meeting.
- Trading in Cardno shares will be suspended on 17 January 2025.
- Cardno will remain an unlisted disclosing entity for 100 or more shareholders.
- The company will adhere to continuous disclosure obligations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Rhythm Biosciences Limited (RHY) ORDINARY FULLY PAID |
Health Care |
$44 |
About the Genetype Acquisition
|
14 Jan 2025 9:16AM |
$0.084 |
$0.135 |
risen by
60.71%
|
|
RHY - Price-sensitive ASX Announcement
Full Release
Key Points
- Rhythm Biosciences has completed an asset acquisition agreement for the Genetype business assets.
- Business integration is targeted for completion in Q1 CY2025.
- The acquisition supports early cancer detection and opens access to a substantial global market.
- It accelerates commercial growth and expands the geographical footprint of Rhythm.
- The geneType product platform is expected to see accelerated sales post-acquisition.
- Rhythm acquired a complete IP portfolio, know-how, and trade secrets related to Genetype.
- The acquisition cost was AUD$625,000 with no legacy debts included.
- Revenue from customer cases after December 24, 2024, will be recognized by Rhythm.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Wellard Limited (WLD) ORDINARY FULLY PAID |
Consumer Staple |
$8 |
Sale of Ocean Drover for USD50M
|
14 Jan 2025 9:15AM |
$0.073 |
$0.015 |
fallen by
79.45%
|
|
WLD - Price-sensitive ASX Announcement
Full Release
Key Points
- Wellard Limited selling M/V Ocean Drover for US$50 million.
- The sale requires shareholder approval.
- Expected completion of sale in July 2025.
- Proceeds to be returned to shareholders (approximately A$0.15 per share).
- Sale marks end of Wellard's 46-year involvement in live export.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pengana Private Equity Trust (PE1) ORDINARY UNITS FULLY PAID |
Financials |
$365 |
Update - Notification of buy-back - PE1
|
14 Jan 2025 9:13AM |
$1.385 |
$1.365 |
fallen by
1.44%
|
|
| Alligator Energy Limited (AGE) ORDINARY FULLY PAID |
Energy |
$146 |
Retention Lease Approved - Samphire Field Recovery Trial
|
14 Jan 2025 9:13AM |
$0.037 |
$0.033 |
fallen by
10.81%
|
|
AGE - Price-sensitive ASX Announcement
Full Release
Key Points
- Retention Lease for Field Recovery Trial granted at Samphire Uranium Project
- Conditions of the lease will be incorporated into the Program for Environment Protection and Rehabilitation
- Approval of the PEPR is the final regulatory step before construction can commence
- Pilot processing plant fabrication completed and stored in Whyalla
- Community engagement efforts are ramping up with new appointments
- FRT will assess key parameters for future production operations
- Operations targeted to commence in Q3 2025 and will last three to four months
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Breville Group Limited (BRG) ORDINARY FULLY PAID |
Consumer Discretionary |
$4,448 |
Notice of FY25 First Half Result and Conference Call
|
14 Jan 2025 9:12AM |
$34.830 |
$30.710 |
fallen by
11.83%
|
|
| PM Capital Global Opportunities Fund Limited (PGF) ORDINARY FULLY PAID |
Financials |
$1,440 |
Monthly Report - 31 December 2024
|
14 Jan 2025 9:10AM |
$2.230 |
$3.000 |
risen by
34.53%
|
|
| Condor Energy Limited (CND) ORDINARY FULLY PAID |
Energy |
$15 |
Trading Halt
|
14 Jan 2025 9:09AM |
$0.019 |
$0.021 |
risen by
10.53%
|
|
CND - Price-sensitive ASX Announcement
Full Release
Key Points
- Condor Energy Limited requested a trading halt.
- The halt is due to an upcoming announcement regarding a resource estimate update.
- The trading halt will end when the announcement is released or on 16 January 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| nanollose Limited (NC6) ORDINARY FULLY PAID |
Health Care |
$20 |
Update - Proposed issue of securities - NC6
|
14 Jan 2025 9:08AM |
$0.019 |
$0.063 |
risen by
231.58%
|
|
| Alpha HPA Limited (A4N) ORDINARY FULLY PAID |
Materials |
$1,016 |
Significant Acceleration in Semiconductor Sector Demand
|
14 Jan 2025 9:08AM |
$0.900 |
$0.890 |
fallen by
1.11%
|
|
A4N - Price-sensitive ASX Announcement
Full Release
Key Points
- Significant lift in demand from the semiconductor sector identified.
- Increased demand primarily from thermal interface materials and CMP slurries.
- Letter of intent received from a market leader for both Stage 1 and Stage 2 of the HPA First Project.
- Alpha's purification process uniquely matches demanding alumina quality requirements.
- Stage 1 production facility adapting to maximize high purity alumina hydrate production.
- Global semiconductor sector experiencing extraordinary growth driven by AI data centers.
- High purity alumina-based demand for better heat management in large data centers.
- Alpha's materials show higher CMP removal rates at lower temperatures, reducing substrate warping.
- Alpha's purification process removes all radio-nuclide impurities, meeting stringent quality standards.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Nanoveu Limited (NVU) ORDINARY FULLY PAID |
Information Technology |
$95 |
Notification of cessation of securities - NVU
|
14 Jan 2025 9:07AM |
$0.034 |
$0.096 |
risen by
182.35%
|
|
| Incitec Pivot Limited (IPL) ORDINARY FULLY PAID |
Materials |
$4,827 |
Update - Notification of buy-back - IPL
|
14 Jan 2025 9:04AM |
$2.940 |
$2.590 |
fallen by
11.90%
|
|
| Nanosonics Limited (NAN) ORDINARY FULLY PAID |
Health Care |
$1,244 |
Appointment of Non-Executive Director and Appendix 3X
|
14 Jan 2025 9:03AM |
$3.280 |
$4.100 |
risen by
25%
|
|
| Vitura Health Limited (VIT) ORDINARY FULLY PAID |
Health Care |
$39 |
Update regarding TGA proceedings
|
14 Jan 2025 9:00AM |
$0.083 |
$0.059 |
fallen by
28.92%
|
|
VIT - Price-sensitive ASX Announcement
Full Release
Key Points
- Vitura Health Limited announced an update regarding TGA proceedings against CDA Clinics Qld.
- Proceedings allege breaches of the Therapeutic Goods Act during 2021.
- CDA Clinics Qld is a dormant entity and not part of Vitura's current operations.
- Vitura is not involved in the alleged breaches and has discontinued funding the defense.
- CDA Clinics Qld is being placed into liquidation.
- The proceedings against CDA Clinics Qld have been stayed.
- Vitura confirms it will not be affected by any court judgment against CDA Clinics Qld.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Keybridge Capital Limited (KBC) ORDINARY FULLY PAID |
Financials |
$10 |
Replacement Notice of General Meeting/Proxy Form
|
14 Jan 2025 9:00AM |
$0.047 |
$0.047 |
fallen by
0%
|
|